Suchita Shah has worked at Boston Consulting Group since October of 2010. She is a core member of BCG’s Health Care practice and has significant experience in biopharma—specifically focused on market access, pricing, commercial strategy, and innovative growth. She is the lead for global value, access, and pricing in biopharmaceuticals.

Suchita helps clients with new product planning by supporting investment decisions and ensuring careful consideration of the relevant market and development drivers.

She supports due diligence efforts by quickly understanding new markets, unmet needs, and how to win. In her recent case work at BCG, Suchita also developed end-to-end disease area strategies to identify key areas for investment, led the strategy development for an imminent competitive threat, supported the US salesforce effectiveness effort to identify HCP value drivers, developed the brand positioning strategy for a launch drug entering a competitive class, and developed creative pricing, reimbursement, and access strategies for a drug entering a highly competitive class of drugs by building the narrative around value derived.

Before joining the firm, Suchita worked at Genentech, Abbott Vascular, and Eli Lilly in commercial and manufacturing roles.

AREAS OF EXPERTISE

  • Disease area strategy
  • Post-merger integration
  • New product planning
  • Due diligence
  • Competitive strategy
  • Market access and pricing
  • Growth
  • Marketing and sales

EDUCATION

  • MBA, The Wharton School, University of Pennsylvania
  • BS, chemical engineering (summa cum laude), University of Michigan
Deep Expertise, Broad Experience